CYTK
NASDAQStockCytokinetics, Incorporated
$59.95-3.65 (-5.74%)
52-Week Range
$29.84
$68.26
Key Stats
Market Cap
7.3B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.51
Volume
1.2M
Avg Volume
2.1M
Performance
1M
-7.48%
3M
-5.29%
6M
+21.36%
YTD
-2.80%
1Y
+36.39%
3Y
+60.99%
5Y
+147.02%
Price Chart
ETF Exposure
CYTK is held by 140 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| HRTS | Tema Cardiovascular and Metabolic ETF | 1.58% |
| JSMD | Janus Henderson Small/Mid Cap Growth Alpha ETF | 1.37% |
| XBI | State Street SPDR S&P Biotech ETF | 1.30% |
| FMED | FIDELITY DISRUPTIVE MEDICINE ETF | 1.22% |
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 1.11% |
| TCAF | T. Rowe Price Capital Appreciation Equity ETF | 1.03% |
| TCAL | T. Rowe Price Capital Appreciation Premium Income ETF | 0.90% |
| GSC | Goldman Sachs Small Cap Equity ETF | 0.88% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.75% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 0.74% |
| FNY | First Trust Mid Cap Growth AlphaDEX Fund | 0.73% |
| SGRW | Harbor Active Small Cap Growth ETF (SGRW) | 0.68% |
| IBB | iShares Biotechnology ETF | 0.67% |
| PAMC | Pacer Lunt MidCap Multi-Factor Alternator ETF | 0.62% |
| HART | NYLI Healthy Hearts ETF | 0.61% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.60% |
| JDOC | JPMorgan Healthcare Leaders ETF | 0.51% |
| IWN | iShares Russell 2000 Value ETF | 0.46% |
| SFYX | SoFi Next 500 ETF | 0.45% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.44% |
| ETHO | Amplify Etho Climate Leadership U.S. ETF | 0.43% |
| SLY | SPDR S&P 600 Small Cap ETF | 0.43% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.41% |
| STXK | Strive Small-Cap ETF | 0.38% |
| FNX | First Trust Mid Cap Core AlphaDEX Fund | 0.36% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.33% |
| SCDS | JPMorgan Fundamental Data Science Small Core ETF | 0.27% |
| XJH | iShares ESG Select Screened S&P Mid-Cap ETF | 0.27% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.27% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.27% |
| RSSL | Global X - Russell 2000 ETF | 0.26% |
| FSMO | Fidelity Small-Mid Cap Opportunities ETF | 0.26% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.26% |
| PWS | Pacer WealthShield ETF | 0.25% |
| IWM | iShares Russell 2000 ETF | 0.25% |
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 0.24% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.24% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 0.24% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 0.24% |
| VBK | Vanguard Small-Cap Growth ETF | 0.24% |
| IJH | iShares Core S&P Mid-Cap ETF | 0.24% |
| JHSC | John Hancock Investments - Multifactor Small Cap ETF | 0.24% |
| SPMD | State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.24% |
| VTWO | Vanguard Russell 2000 ETF | 0.24% |
| MDY | State Street SPDR S&P MIDCAP 400 ETF Trust | 0.23% |
| IVOO | Vanguard S&P Mid-Cap 400 ETF | 0.23% |
| MDYV | State Street SPDR S&P 400 Mid Cap Value ETF | 0.23% |
| IJJ | iShares S&P Mid-Cap 400 Value ETF | 0.23% |
| PTMC | Pacer Trendpilot US Mid Cap ETF | 0.23% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.22% |
Page 1 of 3Next
About CYTK ETF Exposure
Cytokinetics, Incorporated (CYTK) is held by 140 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.3B, CYTK is a widely held institutional stock. The stock currently trades at $59.95. Investors can gain exposure to CYTK through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CYTK, sorted by portfolio weight.